Chelsea Pratt


Genetics Facts for Investors

Punnett squares and phenotypes, chromatids and codominance: genetics, and all of its associated terms, isn’t the easiest field to understand....

March 9th, 2017

The Potential of Transdermal Drug Delivery

Drugs with low oral bioavailability risk failure in clinical trial: minimal absorption, after all, can translate to reduced efficacy. As...

March 2nd, 2017

The CRISPR-Cas9 Patent Dispute

The US Patent Office has ruled “no interference in fact” on CRISPR-Cas9 Patent dispute.

February 15th, 2017

How Medicine Uses Artificial Intelligence

Artificial intelligence is revolutionizing technology, but also medicine. Here’s how.

February 15th, 2017

What Are Mesenchymal Stem Cells?

What exactly are mesenchymal stem cells … and more importantly, why should investors care?

February 9th, 2017

What Are Biologics?

Herceptin, Enbrel, Botox: at first glance, these therapies may appear to have little in common.

February 8th, 2017

10 Drugs Going Off-Patent in 2017

When generic competitors enter the market, sales from a blockbuster drug can decrease significantly.

January 26th, 2017

Beyond Medical Marijuana: Investment Opportunities in Cannabis-Based Biotechs

From serums and masks to oral sprays and enriched waters, we’re counting down the novel ways in which some cannabis-based...

January 25th, 2017

What Is Regenerative Medicine?

The body already has amazing regenerative abilities—can we not harness that power and, in turn, amplify it?

January 18th, 2017

3 Blockbuster Drugs that Changed the Market

These three blockbuster drugs transformed pharmaceutical investing. But will we ever see anything like them again?

January 16th, 2017